| INTRODUCTION
The hepatopulmonary syndrome (HPS) is a disorder characterized by the presence of intrapulmonary vascular dilations (IPVDs) that lead to hypoxemia in patients with liver disease, portal hypertension, or congenital portosystemic shunts. 1 The prevalence of HPS in cirrhotic patients listed for liver transplant varies from 4% to 32%, 2 and its presence affects the quality of life and doubles the risk of death; 3 therefore, recognition of the HPS is essential, particularly in patients in whom liver transplantation is a therapeutic option.
The dilation of pulmonary capillaries-called IPVDs-from the usual diameter of 8-10 μm 4 to 15-60 μm 5, 6 leads to right-to-left shunting, ventilation-perfusion inequality, and O 2 diffusion limitation with resultant hypoxemia. 7 For purposes of defining the HPS, abnormal arterial oxygenation is designated as a resting alveolar-arterial oxygen gradient (A-a O 2 gradient) on room air of ≥15 mm Hg if ≤64 years or ≥20 mm Hg if older, in the absence of other vascular or pulmonary parenchymal abnormalities. 1, 8 Defining features of the HPS include an increased A-a O 2 gradient and evidence of IPVDs 9 for which agitated saline contrast-enhanced echocardiography is a sensitive screening test. 1, 9 Microbubbles (>10 μm in diameter) are generated by agitating normal saline. This agitated solution is then injected in a peripheral vein and a stream of microbubbles opacify the right heart chambers, under normal circumstances to be later filtered by or dissolved in the pulmonary capillary bed. 10, 11 However, in the presence of IPVDs or another source of right-to-left shunt, the microbubbles can traverse or bypass the pulmonary vasculature, appearing in the left heart chambers.
A more pronounced right-to-left shunt has been associated with greater mortality in cirrhotic patients, 12 but there are limited data on whether saline contrast-enhanced echocardiography can help quantify this shunt. In addition, a fundamental unanswered question regards the number of cardiac cycles that need to be reviewed by echocardiography before a significant intrapulmonary shunt can be excluded or the total number of cycles over which bubble appearance should be quantitated. This study examines this issue by characterizing the kinetics of bubble appearance in the left-sided cardiac chambers and comparing these patterns to the results of radionuclide scanning
in a series of patients with advanced liver disease.
| METHODS

| Patient selection
This retrospective study was approved by the Cleveland Clinic
Institutional Review Board (study number (fibrosis and cirrhosis of the liver) with its respective subcodes and/ or K7681 (hepatopulmonary syndrome), and the Current Procedural Terminology (CPT) code 78428 (diagnostic nuclear medicine procedures on the cardiovascular system).
Patients were included if they have liver disease and the presence of both a transthoracic echocardiogram (TTE) with agitated saline contrast and a Tc-99m MAA radionuclide scanning for review. TTE with agitated saline contrast was ordered to screen for HPS and radionuclide scanning to quantify the shunt. Exclusion criteria included the following: (1) The nuclear test was not found (n = 5); (2) TTE with bubbles was not available for offline review (n = 14); (3) the echocardiographic window did not allow an adequate visualization of microbubbles (n = 3); (4) the first image of recorded video showed microbubbles in the RA (n = 10); and (5) fewer than eight heart cycles were recorded after the appearance of microbubbles in the RA (n = 5). We reviewed medical records in all patients to confirm the diagnosis and identify the etiology of cirrhosis. In our series, 42 patients had cirrhosis confirmed by liver biopsy, while the rest had the diagnosis made by liver specialists based on clinical findings and results of imaging studies.
Demographic features, type of liver disease, TTE, and radionuclide scan results were recorded as were results of arterial blood gas (ABG)
analysis by radial artery puncture in the sitting position and on room air (n = 46). The alveolar-arterial O 2 gradient was determined.
| Echocardiography
Following current guidelines, trained sonographers and experienced cardiologists, respectively, performed and interpreted the echocardiograms. 13 All echocardiograms were freshly agitated saline mixed with 1 mL of blood and 0.5 mL of air, while simultaneously recording 2D echocardiography in the four-chamber apical view. 15, 16 Heart cycles were consecutively numbered from 1 to 12, considering number 1 the first R-to-R electrocardiographic interval during which microbubbles were initially noted in the RA. Whenever possible 12 cardiac cycles were captured from the time microbubbles were first observed entering the RA; nevertheless, in five patients the recording stopped at some point between cardiac cycles 8 and 12, potentially related to the fact that in all of them, microbubbles in the left heart chambers were noted between heart cycles 1-4.
KEY POINTS
• Largest study in patients with cirrhosis screened for HPS that investigates the kinetics of microbubbles during agitated saline TTE, using nuclear scanning as comparator.
• Density and timing of appearance of microbubbles on left heart chamber track with severity of right-to-left shunt on nuclear scanning.
• Microbubbles can appear in patients with HPS during the first three beats, even in the absence of patent foramen ovale, likely related to the high cardiac output and large
IPVDs seen in patients with cirrhosis.
• If microbubbles are seen after heart beat number 7, the shunt by nuclear scanning is minimal with marginal effects on systemic oxygenation. heart cycle (after microbubbles were seen in the RA) in which microbubbles were first noted both in the LA and LV was recorded, as was the number of beats required for microbubbles to completely opacify the LA and LV. If microbubbles in the left heart chambers were noted in any of the first three cardiac cycles, we reviewed the transesophageal and/or intracardiac echocardiograms when available.
| Radionuclide scanning
Radionuclide scanning was ordered at the discretion of the treating physicians and was performed at a median (IQR) of 0 (0 -1.8)
months after the echocardiogram with agitated saline. Radionuclide macroaggregated albumin scanning was obtained after the administration of Tc-99m MAA (20 μm, 2-4 mCi) into a peripheral upper extremity vein while the patient was sitting. In the presence of IPVDs, macroaggregated albumin is not fully retained in the pulmonary capillary bed, traveling to the brain and other systemic organs.
Radioactive counts were measured using the geometric mean of the Tc-99m counts in the cerebrum and lungs. We then calculated extrapulmonary shunt fraction, using a method that assumes the brain receives 13% of the total systemic blood flow. 22 In addition, the presence of radioactive uptake in the kidneys, thyroid, spleen, liver, and salivary glands was documented.
| Statistical analysis
Continuous variables were summarized using mean ± standard deviation or median and interquartile range (IQR) when appropriate.
Numerical variables were compared using t test and categorical variables with chi-square test. The degree of association between two variables was tested using the Pearson correlation coefficient.
Receiver operating characteristic curves with Youden's index was used as a criterion for selecting the optimal cutoff point of a continuous variable of interest. All P-values were reported as two-tailed.
A P value of <.05 was considered statistically significant. Statistical analyses were performed using the statistical package SPSS version 17 (IBM; Armonk, NY, USA) and MedCalc version 14.12.2 (MedCalc Software, Ostend, Belgium).
| R E S U LT S
| Patient demographic features and ABG determinations
For the 64 eligible patients, the mean ± SD age was 56 ± 9 years and 34 (53%) were men ( 50-59 mm Hg, n = 15, 34%), and very severe (PaO 2 < 50 mm Hg, n = 5, 11%). 
| Shunt assessment by radionuclide scanning
The median (IQR) shunt fraction by radionuclide scanning was 7.7% (2.8% -19.9%). A total of 46 (72%), 41 (64%), 41 (64%), 39 (61%), and 34 (53%) patients had a shunt fraction ≥ 3%, ≥ 4%, ≥ 5%, ≥ 6%, ≥ 7%, respectively. In the entire cohort, radioactive uptake was clearly noticeable in the brain, kidneys, thyroid, and liver in 50 (78%), 19 (30%), five (8%), and five (8%) patients, respectively. 
T A B L E 1 Patient characteristics and echocardiographic determinations
| Shunt detection by echocardiogram
Selected echocardiographic determinations are presented in Table 1 .
None of the patients had 2D or Doppler evidence of anatomic intracardiac shunt (including PFO, or atrial or ventricular septal defects).
Microbubbles were seen in the LA and LV at a median (IQR) of 4 (2-5) and 4 (2-5) beats, respectively. In the third and fifth cardiac cycles, microbubbles were noted in either the LA or LV in 27 (42%) and 47 (73%) patients, respectively (Table 2, Figure 1 ). The LA was completely opacified with microbubbles at some point during the recording in 44 (69%) patients, at a median (IQR) of seven (6-9) heart cycles. The LV entirely filled with microbubbles in 47 (73%) patients at a median (IQR) of eight (6-10) beats. The density of microbubbles in the LA and LV at each cardiac cycle is shown in Table 2 .
The records of the 28 (44%) patients in whom microbubbles were noted in any of the first three cardiac cycles were carefully reviewed.
Of these 28, four subjects had a PFO (two diagnosed by transesophageal and two by intracardiac echocardiograms) while 12 individuals had no evidence of this condition (eight by transesophageal and four by intra cardiac echocardiograms). These 16 studies (10 transesophageal and six intra cardiac echocardiograms) were performed a median The early ( ≤ 3 heart cycles) appearance of microbubbles in the left heart was associated with a larger nuclear scanning shunt fraction when contrasted with the delayed (>3 cardiac cycles) appearance of microbubbles (17.3 ± 10.9% vs 9 ± 9.5%, P = .003). This significant difference persisted when comparing patients with early appearance of microbubbles without evidence of PFO (n = 12) vs those with delayed appearance of microbubbles in the left heart chambers (18.5 ± 10.2% vs 9.1 ± 9.6%, P = .007). Of patients with RVSP ≥40 mm Hg (n = 21), nine (43%) had early microbubbles, a similar percentage to patients with RVSP <40 mm Hg (46%).
The RV/LV area ratio was inversely associated with the number of heart beats to visualize bubbles in the LA (R = −0.31, P = .02) and directly associated with the density of bubbles in the LA (R = 0.27, P = .04). Similarly, the RV basal diameter was inversely associated T A B L E 2 Presence and density of microbubbles in the LA and LV at each cardiac cycle after the visualization of microbubbles in the RA with number of heart beats to first appearance of bubbles in the LA (R = −0.28, P = .03). No significant associations were noted with the RA area, RA/LA area ratio, and parameters derived from the agitated saline study. The left and right atrium and ventricular areas, their ratio, and RVSP were not significantly associated with the nuclear scan shunt fraction.
| Relationship between shunt detection by echocardiogram and radionuclide scanning
The number of heart cycles in which microbubbles first appeared in the LA or LV was inversely associated with the nuclear scanning shunt fraction (R = −0.42, P = .001 and R = −0.46, P < .001, respectively). In addition, the number of cardiac cycles until the LA and LV were fully opacified with microbubbles (grade 5) was inversely related to the nuclear shunt fraction (R = −0.50, P < .001 and R = −0.52, P < .001, respectively). Table 3 shows the mean ± SD nuclear scanning shunt fraction based on the presence of microbubbles in the LA and LV during the first 12 cardiac cycles, indicating that the nuclear shunt fraction was greater when microbubbles appeared earlier in the left cardiac chambers. A nuclear scanning shunt fraction >7.1% was the optimal cutoff to identify the early appearance of microbubbles in the left heart chambers, with a sensitivity of 82% and specificity of 72%. The density of microbubbles in the LA and LV was significantly associated with the shunt fraction by nuclear scanning, particularly with cardiac cycles five and six (Table 2) . Interestingly, the shunt fraction during nuclear scanning was always below 3% when microbubbles were not seen after cardiac cycle ≥ 7 (Table 3) .
Given the limited number of patients with HPS in the groups with 
| DISCUSSION
The present detailed analysis of the kinetics of microbubble appearance in left-sided cardiac chambers in patients with HPS due to cirrhosis showed that patients with a marked shunt by nuclear scanning have a prompt and pronounced appearance of microbubbles in the LA and LV. In fact, in some patients we saw microbubbles in the left heart chambers during the first three heart cycles, after the appearance in the RA, even in the absence of PFO. The density of microbubbles in the LA and LV correlated best with shunt fraction by nuclear scanning on heart cycles 6-9. Importantly, if no microbubbles were noted by heart cycle 7, the shunt fraction by nuclear scan was uniformly less than 3% in this series. In addition to supporting this provocative interpretation of early microbubble appearance, our study also extends inquiry into the echocardiographic features of the HPS by assessing the kinetics of microbubble appearance and by comparing bubble patterns with the results of nuclear scanning. A key finding was a direct association between the density of microbubbles in the LA and LV and the degree of shunting by nuclear scanning, with the association strongest in cardiac cycles 6-8. It is worth mentioning that maximum microbubble density in the LA and LV was noted after cardiac cycle 7 in a quarter of the patients.
In an earlier study that assessed bubble intensity in cirrhotic patients, Ferreira et al 25 also found a direct association between the degree of right-to-left shunting assessed by contrast echocardiography and nuclear scanning, although specific patterns of bubble appearance by cardiac cycle were not described.
Lung perfusion scanning with Tc-99m MAA is considered abnormal when the extrapulmonary shunt fraction is ≥6%-7%. 22, 26, 27 This test has (1) lower sensitivity (20%-96%) than agitated saline-enhanced echocardiography for detecting intrapulmonary vascular dilations, 22, 28 particularly in less severe cases, (2) does not distinguish intra cardiac from intra pulmonary shunts, and (3) exposes subjects to small doses of radiation. Nevertheless, nuclear scanning is particularly useful in quantifying the shunt and determining the contribution to hypoxemia in patients with lung parenchymal abnormalities. 29 In fact, the extrapulmonary uptake with nuclear scanning is directly proportional to the degree of hypoxemia. [30] [31] [32] More importantly, the extrapulmonary shunt fraction may impact pre-and posttransplant survival as the mean uptake was found to be higher in nonsurvivors than in survivors. 30, 32 We observed that a larger RV was associated with an early appearance of bubbles in the LA, which suggests higher preload and hence RV dilation. The sooner microbubbles appeared in left-sided cardiac chambers, the more pronounced the shunt. Of special note is that if no microbubbles were detected by beat seven, patients uniformly had a shunt fraction by nuclear scanning <3%. This finding supports a practice of evaluating seven cardiac cycles after RV bubble appearance but no more than seven in assessing the presence of an anatomic shunt.
Several limitations of the study warrant comment: First, as echocardiographic assessment study was limited to TTE imaging, it is conceivable that causes of intracardiac shunt (eg, PFO,) might have escaped attention. Still a good proportion of patients had follow-up transesophageal or intra cardiac echocardiograms that rule out an intra cardiac shunt. Second, not all patients had arterial blood gases on room air, thereby limiting the analysis. Finally, selection of eligible patients by ICD-10 codes and the need to have radionuclide scanning may have biased selection and could limit generalizability. In spite of these limitations, our study showed that echocardiography, a test that does not involve radiation and provides valuable cardiovascular information, could also quantify the degree of right-to-left shunt in patients with advanced liver cirrhosis, useful information as a more pronounced right-to-left shunt has been associated with greater hypoxemia and mortality in cirrhotic patients. 12 Because an abnormal degree of shunt was never observed in patients with microbubbles beyond seven cardiac cycles, the absence of bubbles beyond this 7-cycle criterion may obviate the need for Tc-99m MAA in such patients. 2.6 ± 1.6 (0.9-6.9)
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In summary, in patients with advanced cirrhosis, suspected of having hepatopulmonary syndrome, a more pronounced shunt fraction during nuclear scanning is associated with a prompt and more intense appearance of microbubbles in the left-sided heart chambers. Patients with a shunt fraction above 3% have microbubbles in the left atrium or ventricle at some point during the first seven heart cycles after the appearance of microbubbles in the right atrium. Confirmatory studies in cirrhotic patients both with and without HPS will further advance understanding of the kinetics of microbubble appearance. 
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